Elnaz Khodabandehloo

1 ta ish

Hamedan University of Medical Sciences

1. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

   Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.475949